Log In
Print
BCIQ
Print
Print this Print this
 

quilizumab (MEMP1972A) (RG7449)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against M1 prime segment of membrane IgE
Molecular Target Immunoglobulin E (IgE)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat allergic asthma; Treat asthma
Regulatory Designation

Partner

Genentech Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today